These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 12071184)

  • 21. Switching antiretroviral therapy: why, when and how.
    Wilkin T; Glesby M; Gulick RM
    IAPAC Mon; 2006 Jul; 12(7):220-9. PubMed ID: 17096494
    [No Abstract]   [Full Text] [Related]  

  • 22. The need for novel targets and approaches to HIV therapy.
    Martinez LJ
    Res Initiat Treat Action; 2002; 8(1):23-5. PubMed ID: 12489523
    [No Abstract]   [Full Text] [Related]  

  • 23. [Light and shade on the treatment of HIV infection].
    Takata N
    Rinsho Ketsueki; 2001 Jun; 42(6):476-80. PubMed ID: 11505526
    [No Abstract]   [Full Text] [Related]  

  • 24. Anti-HIV agents. Drug holidays.
    TreatmentUpdate; 2003; 15(5):3-4. PubMed ID: 17216856
    [No Abstract]   [Full Text] [Related]  

  • 25. HIV meds: keeping trouble at bay.
    Daughtry LM; Bankston JB; Deshotels JM
    RN; 2002 Feb; 65(2):31-5; quiz 36. PubMed ID: 15328865
    [No Abstract]   [Full Text] [Related]  

  • 26. Anti-HIV agents. New evidence changes guidelines about when to start treatment.
    TreatmentUpdate; 2009 Jan; 21(1):2-4. PubMed ID: 19248282
    [No Abstract]   [Full Text] [Related]  

  • 27. Intention-to-treat analysis of anti-HIV therapies and incidence of drug resistance after a year of treatment.
    Aizawa S; Ida S; Sakai-Hachiya A; Tanaka M; Takahashi Y; Hirabayashi Y; Sugiura W; Kimura S; Oka S
    Jpn J Infect Dis; 1999 Jun; 52(3):129-31. PubMed ID: 10507996
    [No Abstract]   [Full Text] [Related]  

  • 28. Anti-HIV agents. Some researchers call for early HIV therapy.
    TreatmentUpdate; 2007 Jan; 19(1):1-2. PubMed ID: 17390476
    [No Abstract]   [Full Text] [Related]  

  • 29. HIV/AIDS. Experts question danger of 'AIDS superbug'.
    Cohen J
    Science; 2005 Feb; 307(5713):1185. PubMed ID: 15731415
    [No Abstract]   [Full Text] [Related]  

  • 30. A multicentre study to determine the efficacy and tolerability of a combination of nelfinavir (VIRACEPT), zalcitabine (HIVID) and zidovudine in the treatment of HIV infected Nigerian patients.
    Idoko JA; Akinsete L; Abalaka AD; Keshinro LB; Dutse L; Onyenekwe B; Lhekwaba A; Njoku OS; Kehinde MO; Wambebe CO
    West Afr J Med; 2002; 21(2):83-6. PubMed ID: 12403023
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tribulations and trials in HIV disease, Part I.
    Boyle BA
    AIDS Read; 2006 May; 16(5):240-4. PubMed ID: 16764065
    [No Abstract]   [Full Text] [Related]  

  • 32. The causes of HIV antiviral treatment failure.
    Clanon K
    Focus; 2001 Jun; 16(7):5-6. PubMed ID: 11548663
    [No Abstract]   [Full Text] [Related]  

  • 33. Anti-HIV agents. How long will a first regimen last?
    TreatmentUpdate; 2003; 15(5):1-2. PubMed ID: 17219614
    [No Abstract]   [Full Text] [Related]  

  • 34. Researchers note changing patterns of HIV morbidity. Study suggests benefit to starting ART early.
    AIDS Alert; 2007 Oct; 22(10):116-7. PubMed ID: 18416008
    [No Abstract]   [Full Text] [Related]  

  • 35. Ethnicity and treatment.
    Proj Inf Perspect; 1997 Jul; (22):15-6. PubMed ID: 11364573
    [TBL] [Abstract][Full Text] [Related]  

  • 36. How I encourage my patients to take their antiretroviral therapy regularly.
    Walsh J
    J Infect; 1999 Mar; 38(2):ii. PubMed ID: 10342642
    [No Abstract]   [Full Text] [Related]  

  • 37. Uncertainty as to whether the use of antiretroviral therapy for persons recently infected with HIV has a favorable risk-to-benefit ratio.
    Lundgren JD; Phillips AN; Neaton J
    Clin Infect Dis; 2009 Apr; 48(8):1162; author reply 1162-3. PubMed ID: 19292638
    [No Abstract]   [Full Text] [Related]  

  • 38. Zidovudine and red-cell distribution width.
    Rivas P; Górgolas M; Fernández-Guerrero ML
    N Engl J Med; 2005 May; 352(20):2141-2. PubMed ID: 15901876
    [No Abstract]   [Full Text] [Related]  

  • 39. Anti-HIV agents. Is FOTO a treatment interruption that works?
    TreatmentUpdate; 2005; 17(5):10-1. PubMed ID: 17219661
    [No Abstract]   [Full Text] [Related]  

  • 40. [Favorable new data for nevirapine. Antiretroviral effect confirmed--and also lipid profile].
    MMW Fortschr Med; 2004 Apr; 146 Spec No 1():58-60. PubMed ID: 15373051
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.